Prestige Consumer Healthcare
285 hedge funds and large institutions have $2.98B invested in Prestige Consumer Healthcare in 2022 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 99 increasing their positions, 121 reducing their positions, and 30 closing their positions.
17% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 30
16% more capital invested
Capital invested by funds: $2.57B → $2.98B (+$409M)
1.27% more ownership
Funds ownership: 100.34% → 101.61% (+1.3%)
1% less funds holding
Funds holding: 287 → 285 (-2)
18% less repeat investments, than reductions
Existing positions increased: 99 | Existing positions reduced: 121
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Ariel Investments
Chicago,
Illinois
|
+$41.9M |
| 2 |
OAM
Ophir Asset Management
Sydney,
Australia
|
+$39.8M |
| 3 |
Morgan Stanley
New York
|
+$24.7M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$21.4M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$14M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$36M |
| 2 |
Man Group
London,
United Kingdom
|
-$15.3M |
| 3 |
Goldman Sachs
New York
|
-$10.8M |
| 4 |
KIM
Kestrel Investment Management
San Mateo,
California
|
-$7.03M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$6.2M |
PBH Hedge Fund Activity: Q2 2022 in Review
285 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Prestige Consumer Healthcare (PBH) for Q2 2022, worth a combined $2.98B — up 16% from $2.57B a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new PBH positions and 30 closed out — a net gain of 5 holders — while 99 added to existing stakes and 121 trimmed.
The largest buyer was Ariel Investments, opening a new position worth an estimated $41.9M. The largest seller was Fidelity Investments, cutting an estimated $36M.
- 285 institutional investors held Prestige Consumer Healthcare (PBH) as of Q2 2022, down from 287 in Q1 2022.
- Funds reported $2.98B of Prestige Consumer Healthcare stock for Q2 2022, up 16% quarter-over-quarter.
- 35 funds opened new Prestige Consumer Healthcare positions in Q2 2022 and 30 closed out, a net change of +5 holders.
- The largest Prestige Consumer Healthcare buyer in Q2 2022 was Ariel Investments, an estimated $41.9M added.
- The largest Prestige Consumer Healthcare seller in Q2 2022 was Fidelity Investments, an estimated $36M sold.
Based on aggregated 13F filings for Q2 2022.